Alerts will be sent to your verified email
Verify Email
NATCOPHARM
Insufficient data
Positive for this company
Neutral for this company
Negative for this company
Insufficient data to analyse
Natco Pharma Limited is a vertically integrated pharmaceutical company that focuses on developing, manufacturing, and marketing pharmaceutical products, along with offering contract manufacturing services and crop health sciences division.
Natco Pharma major competitors are Caplin Point Lab, Jubilant Pharmova, Alembic Pharma, Sanofi India, Procter&Gamble Healt, Astrazeneca Pharma I, Strides Pharma Scien.
Market Cap of Natco Pharma is ₹15,489 Crs.
While the median market cap of its peers are ₹16,028 Crs.
Natco Pharma seems to be less financially stable compared to its competitors.
Altman Z score of Natco Pharma is 12.52 and is ranked 4 out of its 8 competitors.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annual Report | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | ||
| Earnings Release | May Aug | Sep Dec | Mar Jun Sep Dec | Jun Sep | Mar Jun Sep Dec | Mar Jun Sep Dec | Sep | |||||||||||
| Investor Presentation | May Jul Aug | Feb Mar Jun Sep Dec | Mar Jun Sep Dec | Feb Mar Jun Aug Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Dec | Mar Jun Sep Dec | Mar Sep Dec | Mar Jun Sep Dec | Sep Dec | Mar Sep | ||||||
| Conference Call | Mar Jun | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Jun Sep Dec | |||||||
|
Conference Call SummaryCon Call Summary
Powered by Gemini
|
